ER HER2 PR breast Cancer genome sequencing
|Study ID||Alternative Stable ID||Type|
Agilent whole exome hybridisation capture will be performed on genomic DNA derived from X triple negative breast cancers and matched normal DNA from the same patients. Three lanes of Illumina GA sequencing will be performed on the resulting X exome libraries and mapped to build 37 of the human reference genome to facilitate the identification of novel cancer genes.
Study Datasets 2 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
ER-, HER2-, PR- breast Cancer genome sequencing
|Illumina Genome Analyzer II||6|
The landscape of cancer genes and mutational processes in breast cancer
|Illumina Genome Analyzer II,Illumina HiSeq 2000||199|
Who archives the data?